475 related articles for article (PubMed ID: 7950904)
1. Impaired growth hormone secretion in patients operated for pituitary adenomas.
Hoeck HC; Bang F; Laurberg P
Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
[TBL] [Abstract][Full Text] [Related]
2. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
Lastoria S; Colao A; Vergara E; Ferone D; Varrella P; Merola B; Lombardi G; Salvatore M
Eur J Endocrinol; 1995 Jul; 133(1):38-47. PubMed ID: 7627336
[TBL] [Abstract][Full Text] [Related]
4. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
Arafah BM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
[TBL] [Abstract][Full Text] [Related]
5. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
7. Follicle-stimulating hormone-secreting pituitary adenomas.
Beckers A; Stevenaert A; Mashiter K; Hennen G
J Clin Endocrinol Metab; 1985 Sep; 61(3):525-8. PubMed ID: 2991325
[TBL] [Abstract][Full Text] [Related]
8. [Pituitary apoplexy: analysis of endocrine function in 17 cases].
Fernández Real JM; Villabona CM; Montaña E; Acebes JJ; Ricart W; Sahún M; Gómez JM; Soler J
Med Clin (Barc); 1991 Apr; 96(14):521-4. PubMed ID: 2051802
[TBL] [Abstract][Full Text] [Related]
9. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
[TBL] [Abstract][Full Text] [Related]
10. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
13. The hormonal profile of hypophysial adenomas demonstrates the existence of the secretory interdependence of the pituitary cells.
Fonseca ME; Morán C; Zárate A; Loyo M
Arch Invest Med (Mex); 1984; 15(4):317-30. PubMed ID: 6100161
[No Abstract] [Full Text] [Related]
14. Pituitary stimulation by combined administration of four hypothalamic releasing hormones in normal men and patients.
Cohen R; Bouquier D; Biot-Laporte S; Vermeulen E; Claustrat B; Cherpin MH; Cabrera P; Guidetti P; Ferry S; Bizollon CA
J Clin Endocrinol Metab; 1986 May; 62(5):892-8. PubMed ID: 3007559
[TBL] [Abstract][Full Text] [Related]
15. [Endocrinological analysis of pituitary adenomas associated with hyperprolactinemia (author's transl)].
Sato O; Hotta H; Nakagawa T; Sohma F; Hasunuma M; Tsuchita H; Tanabe S; Kobayashi K; Inoue Y
No To Shinkei; 1981 Nov; 33(11):1115-23. PubMed ID: 6277351
[No Abstract] [Full Text] [Related]
16. [Endocrine diagnosis of pituitary adenomas (author's transl)].
Nakai Y; Oki S; Nakao K; Fukada J; Kinoshita F; Tanaka K; Tsukada T; Imura H
No To Shinkei; 1981 May; 33(5):431-40. PubMed ID: 6266437
[No Abstract] [Full Text] [Related]
17. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
Li GM; Sun XJ; Shao P
Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
[TBL] [Abstract][Full Text] [Related]
18. Alpha-subunit immunoreactivity in plurihormonal pituitary adenomas of patients with acromegaly.
Kontogeorgos G; Kovacs K; Scheithauer BW; Rologis D; Orphanidis G
Mod Pathol; 1991 Mar; 4(2):191-5. PubMed ID: 1646455
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
20. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]